Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
cetuximab, CI, cohort, comparison, confirm, confirmed, COO, CRC, death, diagnosed, entitling, experimental, exploratory, formal, group, guided, IHC, immunohistochemistry, irinotecan, METIV, Objective, ORR, pathway, permanently, pre, predict, published, put, receipt, reclassed, refractory, regained, regional, relapsed, role, salary, SAP, suspend, systemic, thousand, tolerated, undergoing
Removed:
academic, achieve, activated, add, AKIP, anemia, apply, applying, arrest, BID, biology, cellular, characterize, chemotherapy, compare, consecutive, consolidated, declined, dependent, developed, dose, dosed, enhanced, establishing, evolving, existing, expand, expansion, expire, extension, face, fatigue, genotyping, greater, harbor, hematologic, incidence, incorporated, inflow, inhibition, interpretation, investigate, involvement, light, log, mechanism, mitotic, newly, prospective, rank, reclassification, reduction, remained, retrospectively, roll, selected, showing, signaling, suggesting, tested, Topic, unclear, undetectable
Filing tables
Filing exhibits
Related press release
ARQL similar filings
Filing view
External links